| Offering Information |
| Expected Date | TBA |
| Proposed Exchange/Ticker |
NYSE: CDH |
| Security Type |
Common Stock |
| Lead Underwriter |
Donaldson Lufkin & Jenrette |
| Days In Registration |
- |
| Date Filed |
5-Jun-1998 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Wholesale |
| Business Description |
Wholesale drugs and pharmaceuticals |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Chief Executive Officer |
Robert C. Farley |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
4.75M |
| Secondary Shares Filed | 1.25M |
| · As a Percent |
26.3 |
| Primary Shares Filed |
3.5M |
| · As a Percent |
73.7 |
| Overallotment Shares Filed |
712.5K |
| File Amount |
$80.75M |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
|
